from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3828c/-

LFCtreatmentdescriptionclass of inhibitor

-1.352

Amikacinug/mL Amikacintranslation

-1.307

Cap5-10ug/mL Capreomycintranslation

-1.395

Rox10-50 ug/mL Roxithromycintranslation

-0.678

SM2-5 ug/mL Streptomycintranslation

-1.685

Tet5-10 ug/mL Tetracyclinetranslation

0.079

Rif0.2-5ug/mL Rifampicintranscription

-1.508

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.222

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.071

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.023

CPZ10-50 ug/mL Chlorpromazinerespiration

0.113

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.737

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.216

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.085

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.115

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.511

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.402

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.339

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.230

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.122

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.534

KCN5-20 ug/mL Potassium cyaniderespiration

-0.127

NaN30.2-2 mM Sodium aziderespiration

-0.321

Nigericin50 uM Nigericinrespiration

0.741

TRC10-150 ug/mL Triclosanrespiration

0.851

TRZ10-25 ug/mL Thioridazinerespiration

-0.134

Valinomycin0.5-10 uM Valinomycinrespiration

-1.452

ZnSO42 mM ZnSO4respiration

0.426

menadione6-10 ug/mL Menadionerespiration

-0.163

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.513

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.032

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.611

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.199

NRP_1Non-replicating persistence stage 1dosRassociated

-0.321

Amp0.2mg/mL AmpicillincellWall

-0.433

Cephalexin20-100 ug/mL CephalexincellWall

-0.684

Cerulenin0.32-5 ug/mL CerulenincellWall

0.247

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.047

EMB10-20 ug/mL EthambutolcellWall

-1.152

Eta12-40 ug/mL EthionamidecellWall

-1.135

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.411

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.566

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.042

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.049

BZA0.12 mg/mL BenzamidearomaticAmides

0.063

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.139

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.925

H2O24 mM hydrogen peroxideDNAdamaging

1.033

Levo10 ug/mL LevofloxacinDNAdamaging

0.662

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.922

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.597

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.662

UVUV-irradiationDNAdamaging

0.675

ARP41-4 ug/mL Antitubercular compound ARP4?

0.102

Antimycin12.5-50 ug/mL Antimycin A?

-0.844

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.379

PA_110-50 ug/mL Antitubercular compound PA-1?

0.506

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.073

PA8240.2-2 ug/mL PA-824?

0.347

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.296

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.702

Verapamil50 uM Verapamil?

-0.897

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.833

methoxatin10-20 ug/mL Methoxatin?